Prof. Chen Jie: 2020, My NET Road

Content from Professor Chen Jie's WeChat public number authorization, welcome to pay attention to Professor Chen Jie WeChat public number: neuroendocrine oncologist Chen Jie! 2020, My NET Road 2020, is a special year, a sudden new crown outbreak that has changed the lives of each of us to a great extent and affected everyone's work to varying degrees.
2020 and my 10th year in the NET field.
Let's start with a few numbers, and in 2020, although medical care was almost stagnant in the first quarter due to the new crown outbreak, I still treated 760 new patients with neuroendocrine tumors from all over the country (648 in 2019), 90% of whom were from outside Guangzhou, and 60% of whom were patients. From outside Guangdong Province, our Nuclear Medicine Department performed 68Ga growth inhibitor PET-CT scans on 613 of these patients (464 in 2019), and our MDT team conducted MDT discussions for 366 of these patients (334 in 2019) to develop a reasonable treatment plan for them.
look at another set of numbers.
In 2020, the total number of neuroendocrine tumor patients I've answered questions in Good Doctor's Online My Online Clinic has reached 4,818 (3,228 in 2019), thanks to the online age we're in, which provides doctors and patients with such a convenient and efficient way to communicate online.
In 2020, because of the new crown of the epidemic, whether it is Internet consultation, or network academic conferences, have been popularized in unprecedented depth, this is not a good thing, and our 9th neuroendocrine tumor diagnosis and treatment training course, as well as the 5th Neuroendocrine Oncology Forum in September, the Golden Autumn Line held simultaneously.
In addition, we almost every weekend held a variety of neuroendocrine tumor MDT online seminars, we launched a series of neuroendocrine tumor lectures on the official website of the digestive community, have become the vast number of peers and patients to understand and learn about the disease's best online teaching materials.
2020, as a speaker, he was invited to three online international academic conferences, including the ENETS Annual Meeting in March, the World NET Forum hosted by Israel in August, and the IASGO and KSGC Joint Forum in South Korea in September.
was very surprised to receive a special gift from the European EsMO on Christmas Eve 2020 and was invited to join ESMO as a member of the Neuroendocrine and Endocrine Oncology Group, one of its 19 professional groups.
2020, we will continue to identify problems from the clinical, ask questions, on the basis of which a number of neuroendocrine tumor-related research has been carried out.
we have explored the immunologic micro-environment of neuroendocrine tumors (Endocrine. 2020.); The genetic esotesis of colon neuroendocrine cancer (Clinical Colorectal Cancer). 2020; explores how to judge the malignancy of rectal neuroendocrine tumors by imaging under the common colonoscopy (Endoscopy 2020); and explores the upper limit of the Ki-67 index of G3 gastrointestinal and pancreatic endocrine tumors (Journal of Gastrointestinal Surgery. 2020; Pancreas. 2020); explores how to predict the efficacy of the catin chemotherapy program through the Ki-67 index (Neuroendocrinology. 2020）。
, as well as our team's ultrasound and tumor intervention partners, are exploring all aspects of neuroendocrine cancer diagnosis and treatment from their own clinical perspectives.
In 2020, our team successfully treated many difficult cases of neuroendocrine tumors, but also found more and more clinically difficult problems: the therapeutic ceiling of neuroendocrine cancer is still unbreakable; The treatment of endocrine tumors is extremely challenging, neuroendocrine tumor patients have a trend of getting older and older, especially in children non-genetically related neuroendocrine tumors continue to appear, neuroendocrine tumors, especially pancreatic neuroendocrine tumors of space-time heterogeneity also bring great difficulties in clinical treatment ... But that's what drives our team to move forward and explore this area.
2021, move on! Chen Jie Source: Neuroendocrine Oncologist Chen Jie Copyright Notice: All text, images and audio and video materials that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Mets Medicine and are not authorized to be reproduced by any media, website or individual, and must be reproduced with the words "Source: Mets Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
at the same time reproduced content does not represent the position of this site.
leave a message here